SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-123645
Filing Date
2022-04-27
Accepted
2022-04-27 16:16:26
Documents
13
Period of Report
2022-04-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d353461d8k.htm   iXBRL 8-K 26995
2 EX-3.1 d353461dex31.htm EX-3.1 9717
  Complete submission text file 0001193125-22-123645.txt   166086

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20220422.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20220422_lab.xml EX-101.LAB 18741
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20220422_pre.xml EX-101.PRE 11725
7 EXTRACTED XBRL INSTANCE DOCUMENT d353461d8k_htm.xml XML 3621
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 22859775
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences